Investigational Site Number 2330002

Pärnu 80018

0 studies enrolling now · 2 studies all time

What they study most

Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early